Curcumin (Turmeric Extract)
Research indicates curcumin may support anti-inflammatory pathways and cellular health through multiple mechanisms.
Human Trials
150
8,500 participants
Risk Level
Monthly Cost
Higher-end formulations with enhanced bioavailability cost more
Quick Facts
- Category
- Supplement
- Research Field
- Supplements
- Evidence Grade
- B – Moderate
- Risk Level
- Low
- Monthly Cost
- $15 – $60
- Human Trials
- 150
Typical Dose
500–1000 mg/day of curcumin extract
Range
250–2000 mg/day
For informational purposes only – not medical advice. See disclaimer
Research Velocity
Mechanism of Action
Curcumin appears to modulate multiple cellular pathways, including inhibition of NF-κB transcription factor, which regulates inflammatory gene expression. Studies suggest it may influence cyclooxygenase and lipoxygenase enzymes, potentially affecting prostaglandin and leukotriene synthesis. Research indicates curcumin may also activate Nrf2 pathways involved in antioxidant response and support mitochondrial function through various cellular signaling cascades.
Overview
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), has been extensively studied for its potential health benefits. Research indicates it may support various aspects of cellular health through anti-inflammatory and antioxidant mechanisms. Multiple human trials have investigated curcumin's effects on inflammatory markers, joint health, cognitive function, and cardiovascular parameters, with many studies suggesting modest but consistent benefits.
One significant challenge with curcumin supplementation is bioavailability, as standard curcumin is poorly absorbed and rapidly metabolized. This has led to the development of enhanced formulations including curcumin with piperine (black pepper extract), liposomal curcumin, and curcumin phytosomes, which research suggests may improve absorption by 20-2000%. Studies indicate that these enhanced formulations may be more effective at achieving therapeutic tissue levels.
While generally well-tolerated, curcumin supplements may cause gastrointestinal upset in some individuals and can interact with certain medications. Research suggests optimal dosing typically ranges from 500-1000mg daily of enhanced bioavailability formulations, though studies have used varying doses and formulations, making direct comparisons challenging.
Known Interactions
- May increase bleeding risk when combined with anticoagulant medications
- Can enhance effects of diabetes medications, potentially causing hypoglycemia
- May interfere with chemotherapy drugs by reducing their effectiveness
- Can increase absorption of certain medications due to P-glycoprotein inhibition
Legal Status by Country
Your country (United States)
Available without prescription in:
Australia, Brazil, Canada, China, Colombia, Germany, India, Israel, Japan, Mexico, Netherlands, Panama, Russia, South Korea, Switzerland, Thailand, Turkey, UAE, United Kingdom, United States
📍 = your selected country · ✈️ = medical tourism destination · Always verify current local regulations before travel.
Key Research
- 2020
Comprehensive meta-analysis of anti-inflammatory effects
- 2017
Reviews bioavailability challenges and enhancement strategies
- 2018
Systematic review of cognitive benefits
- 2019Curcumin supplementation and recovery from exercise-induced muscle damage
Exercise recovery and anti-inflammatory effects
- 2021Molecular mechanisms of curcumin in aging and age-related diseases
Longevity-related molecular pathways
Related Interventions
Acetyl-L-Carnitine (ALCAR)
Research suggests acetyl-L-carnitine may support mitochondrial function, cognitive performance, and cellular energy metabolism.
Alpha-Lipoic Acid
A potent antioxidant supplement that research indicates may improve insulin sensitivity and reduce oxidative stress.
Apigenin
Research suggests apigenin, a flavonoid found in chamomile and parsley, may support cellular longevity through multiple anti-aging pathways.
Ashwagandha (KSM-66)
Adaptogenic herb showing promise for stress reduction, cortisol management, and cognitive function in multiple human trials.
Last verified: 2026-03-16